glp-1 and stroke Risk of major adverse cardiovascular events associated with treatment with or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis GLP-1 receptor agonists in stroke
Description
Diabetologia 67 , 528546 (2024)
Nuche-Berenguer B, Lozano D, Gutirrez-Rojas I, Moreno P, Marioso ML, Esbrit P, Villanueva-Peacarrillo ML
At least some of these benefits stem from weight loss itself
This is when you lose fat and gain a small amount of muscle at the same time
If youd like a complete overview of how these medications work, visit our GLP-1 Weight Loss: Complete Guide
At Cape Fear Physical Medicine and Rehab, we are committed to helping individuals improve their health, manage chronic conditions, and achieve sustainable weight loss
